Pasireotide monotherapy in Cushing's disease: a single-centre experience with 5-year extension of phase III Trial (Q33163578)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Pasireotide monotherapy in Cushing's disease: a single-centre experience with 5-year extension of phase III Trial |
scientific article |
Statements
1 reference
Pasireotide monotherapy in Cushing's disease: a single-centre experience with 5-year extension of phase III Trial (English)
1 reference
Isabelle Bourdeau
1 reference
André Lacroix
1 reference
Jessica MacKenzie Feder
1 reference
Sophie Vallette
1 reference
Hugues Beauregard
1 reference
Louis-Georges Ste-Marie
1 reference
1 December 2014
1 reference
1 reference
17
1 reference
519-529
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference